The University of Bristol is inviting applications for a fully funded PhD studentship in Dr. Katja Klein's lab, focusing on the design and evaluation of VLP- and saRNA-based vaccines with modular peptide string constructs to elicit broad-spectrum adaptive immune responses against influenza. This research integrates advanced concepts in vaccine design, immunology, virology, and cell biology, using influenza as a model system to explore immune mechanisms and pathogen transmission. Dr. Klein, Lecturer in Endemic, Enzootic and Emerging Infectious Diseases at Bristol Veterinary School, leads research on viral transmission and immune responses to globally significant pathogens including HIV-1, SARS-CoV-2, and influenza A virus.

The SWBio Doctoral Training Partnership offers a cohort-based programme with an integrated taught first year, starting in September 2026. The studentship is fully funded for 4 years, covering tuition fees and providing a stipend. Applicants must have a strong academic background in biological sciences, medical science, or related fields, with a bachelor's or master's degree required. Experience in immunology, virology, or vaccine research is highly desirable. The programme supports flexible working, project adaptations, and part-time study options for home students. International applicants must meet visa requirements and attend in person at the host institution. Previous PhD holders are not eligible.

To apply, candidates must submit their application through the SWBio DTP centralised application system (Good Grants) by December 3, 2025. Registration for an account and completion of all required information, including academic transcripts, references, and motivation statements, is necessary. For more details on the project and application process, visit the provided links or contact Dr. Katja Klein or the SWBio DTP team. The programme values diversity and inclusion, welcoming applicants from all backgrounds and career paths.

Key research areas include vaccine design, immunology, virology, influenza, saRNA, VLP, adaptive immune response, and pathogen transmission. The University of Bristol provides a vibrant research environment with access to state-of-the-art facilities and expert supervision.